CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Support from the isotope production and distribution program fund
4.1.2. Increasing R&D activities in the Pharmaceutical & Biotechnology sector
4.1.3. Growing proteomics research
4.1.4. Increasing prevalence of cancer
4.1.5. Favourable scenario for environmental research
4.2. Market Restraints & Challenges
4.2.1. The high cost of stable isotope labelled compounds
4.2.2. Lack of skilled professionals
4.3. Market Opportunities
4.3.1. Growing investments in pharmaceutical R&D in emerging markets
CHAPTER 5. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET – BY
TYPE
5.1. Deuterium
5.2. Carbon-13
5.3. Oxygen-18
5.4. Nitrogen-15
5.5. Others
CHAPTER 6. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET –
BY APPLICATION
6.1. Research
6.1.1. Pharmaceutical Research
6.1.2. Biomedical Research
6.1.3. Environmental & Ecological Research
6.1.4. Agricultural Research
6.2. Clinical Diagnostics
6.3. Industrial
6.4. Others
CHAPTER 7. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET – BY
END USER
7.1. Pharmaceutical & Biotechnology Companies
7.2. Academic & Research Institutes
7.3. Hospitals & Diagnostics Centers
7.4. Others
CHAPTER 8. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET - BY
GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET -
COMPANY PROFILES
9.1. Isosciences, LLC
9.2. Urenco Limited
9.3. Merck KGaA
9.4. Omicron Biochemicals, Inc.
9.5. Nordion, Inc.
9.6. Rotem Industries Israel Ltd.
9.7. Medical Isotopes, Inc.
9.8. Cambridge Isotope Laboratories, Inc.
9.9. Trace Science International
9.10. Alsachim
9.11. Perkinelmer Inc.
9.12. Taiyo Nippon Sanso Corporation
9.13. 3M
9.14. 13 C Molecular
9.15. Marshall Isotopes Ltd.
CHAPTER 10. GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET -
COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
